The 584 reply needs to tackle this

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

optymystic

Rank: President [?]

Points: 18922 [?]

Votes: 159 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

The 584 reply needs to tackle this

posted on Feb 10, 2009 12:34PM

Form the rejection

<The Patent Owner while arguing that the method of Pomerene is not suitable for use in a microprocessor system provides no evidence as to why it is not suitable. >

Proving that the invention is suitable for the purpose intended is not sufficient. Patent owner needs to prove that examiner combinations of prior art are not workable. A la the 148. That process can go on forever, which is why I hope Moore can somehow put a stop to it. Opty

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply